amifostine anhydrous has been researched along with Cystic Fibrosis of Pancreas in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It is well absorbed (23%) after oral administration to rabbits." | 1.26 | Studies on the reduction of sputum viscosity in cystic fibrosis using an orally absorbed protected thiol. ( Cerami, A; Peterson, CM; Tabachnik, NF, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tabachnik, NF | 2 |
| Peterson, CM | 2 |
| Cerami, A | 2 |
| Blackburn, P | 1 |
2 other studies available for amifostine anhydrous and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Studies on the reduction of sputum viscosity in cystic fibrosis using an orally absorbed protected thiol.
Topics: Adolescent; Adult; Amifostine; Animals; Child; Cystic Fibrosis; Diamines; Expectorants; Humans; In V | 1980 |
Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR 2721.
Topics: Administration, Oral; Amifostine; Animals; Biotransformation; Blood Proteins; Cystic Fibrosis; Diami | 1982 |